Skip to main content
logo
Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
22.11
+0.85 (4.00%)
At close: May 28, 2026, 4:00 PM EDT
22.49
+0.38 (1.72%)
After-hours: May 28, 2026, 5:39 PM EDT

Castle Biosciences Revenue

Castle Biosciences had revenue of $83.68M in the quarter ending March 31, 2026, a decrease of -4.90%. This brings the company's revenue in the last twelve months to $339.92M, down -2.06% year-over-year. In the year 2025, Castle Biosciences had annual revenue of $344.23M with 3.66% growth.

Revenue (ttm)
$339.92M
Revenue Growth
-2.06%
P/S Ratio
1.96
Revenue / Employee
$360,849
Employees
942
Market Cap
670.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025344.23M12.16M3.66%
Dec 31, 2024332.07M112.28M51.09%
Dec 31, 2023219.79M82.75M60.38%
Dec 31, 2022137.04M42.95M45.65%
Dec 31, 202194.09M31.44M50.18%
Dec 31, 202062.65M10.78M20.79%
Dec 31, 201951.87M29.08M127.62%
Dec 31, 201822.79M9.03M65.67%
Dec 31, 201713.75M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics829.00M
NeoGenomics745.97M
OPKO Health581.12M
GeneDx Holdings442.68M
CareDx412.82M
Fulgent Genetics320.35M
Adaptive Biotechnologies295.41M
Biodesix96.10M
Revenue Rankings

CSTL News

More News